(Q43621682)

English

Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia? (English)

1 reference

Europe PubMed Central

25 November 2017

0 references

1 reference

based on heuristic

inferred from title

1

object named as

Robak T

1 reference

Europe PubMed Central

25 November 2017

author name string

Błoński JZ

2

1 reference

Europe PubMed Central

25 November 2017

Kasznicki M

3

1 reference

Europe PubMed Central

25 November 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

25 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

25 November 2017

41

1 reference

Europe PubMed Central

25 November 2017

545-557

1 reference

Europe PubMed Central

25 November 2017

5-6

1 reference

Europe PubMed Central

25 November 2017

Chronic lymphocytic leukaemia treatment

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Key issues in the treatment of chronic lymphocytic leukaemia (CLL)

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Phase I/II study of 2-chloro-2'-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060345

21 January 2018

Identifiers

10.3109/10428190109060345

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43621682&oldid=2118185088"